ESOF 2010EMCDDA ScC Session

Marina Davoli, Roland Simon, Margareta Nilson

2

State of development

Luigi Civalleri - ESOF2010 - Scientific Programme Coordinator Via Po 18, 10123 Torino (Italy)

• “on behalf of ESOF2010 Programme Committee and organizing team, I congratulate all successful proponents. Welcome on board!”

• 218 proposals from 26 countries received/ 97 proposals were accepted

Questions to be answered soon:• 1. Speakers confirmed? Is the affiliation you provided correct?• 2. Moderator chosen?• 3. Date fixed? • 4. Do you confirm that your session will be completely self-financed?

3

ESOF2010 Torino 3. – 7. July

110 ordinary sessions, 4 Plenary Sessions and 18 Keynote Talks

5 Nobel Prize winners.

Speakers with scientific pre-eminence and communication skills, cultural and gender diversity

Themes• Sustainable living and moving • Evolution, development and adaptation of organisms • Moving into and up from our quantum world • Responding to global needs • Frontiers in energy research • Science, knowledge and belief • Memory and learning in organisms, social and artificial systems • Languages, cultures and variability • Integrating science with health care • Policy – what follows?

4

Some facts on ESOF2008

• Number of total participants: 4115• Number of accredited media: 511• Number of speakers: 452

• Session’s attendance:• - Plenary sessions: an average of 312• - Keynote and parallel sessions: an average of 104• Total number of Outreach participants: 10.000

5

The EMCDDA ScC Session: Synposis

• experiences and possibilities to improve implementation of findings• describes how research has informed clinical practice and what problems

this process can face. • Clinical research on pharmacological and psychosocial treatment has

changed the understanding and treatment of addictions, whereas behavioural treatment has partly developed through advances in qualitative research.

Compared to first proposal: cut down by 50%, concentrated on treatment

6

The EMCDDA ScC Session: Structure

Research informing clinical practice – what works, and what does notWhere transfer works/worked for pharmacological treatment John Strang 10’

Where transfer works/worked for psychosocial/behavioural treatment Michael Farrell 10’

What limits and hinders transfer Jurgen Rehm 15’

Part II: Research informing practice – ways to narrow the gapFrom research synthesis to clinical guidelines Marina Davoli 10’

Are guidelines of any use to clinicians? PierPaolo Pani 10’

Discussion with the panel: Ways to narrow the gap 20’

Overall duration: 75 Minutes

7

Next steps

• Finalize list of speakers• Agree on outline of presentations• Guarantee funding and organise trips

We will support Marina and Michael doing this